What is Pf-08049820 Ir used for?

Pf-08049820 Ir is indicated for Indication not found, Indication not found.

Who makes Pf-08049820 Ir?

Pf-08049820 Ir is developed by Pfizer.

What development phase is Pf-08049820 Ir in?

Pf-08049820 Ir is FDA-approved (marketed).

What is the generic name of Pf-08049820 Ir?

pf-08049820-ir is the generic (nonproprietary) name of Pf-08049820 Ir.

Last reviewed 2026-04-20 · How we verify

Pf-08049820 Ir (pf-08049820-ir)

Pfizer · FDA-approved active Quality 22/100

At a glance

Generic name	pf-08049820-ir
Sponsor	Pfizer
Drug class	Unknown
Target	Unknown
Therapeutic area	Other
Phase	FDA-approved

Approved indications

Indication not found
Indication not found

Common side effects

No common side effects on file.

Drug interactions

Warfarin
Aspirin
Pentobarbital
Phenobarbital
Rivaroxaban
Apixaban
Dabigatran
Clopidogrel
Ticagrelor
Prasugrel
Cilostazol
Dipyridamole

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pf-08049820 Ir CI brief — competitive landscape report
Pf-08049820 Ir updates RSS · CI watch RSS
Pfizer portfolio CI